TMO EPM / Hemato H9J

TMO EPM / Hemato H9J

血液学と骨髄移植に関する重要なテーマを、サンパウロ医科大学と9月病院の専門家と共に探求します。

Listen on Apple Podcasts

58 - Ibrutinib plus venetoclax in relapsed or refractory mantle cell lymphoma (SYMPATICO): a multicentre, randomised,double-blind, placebo controlled, phase 3 study

S1 E58 • 34 mins • Jul 13, 2025

Charts

This show is not currently ranked in any charts.

最近のエピソード

Jul 13, 2025

58 - Ibrutinib plus venetoclax in relapsed or refractory mantle cell lymphoma (SYMPATICO): a multicentre, randomised,double-blind, placebo controlled, phase 3 study

S1 E58 • 34 mins

Jul 6, 2025

57 - A randomized phase 2 trial of oral vitamin A for graft-versus-host disease in children and young adults

S1 E57 • 30 mins

Jun 29, 2025

56 - Fixed-Duration Ibrutinib-Venetoclax in Patients with Chronic Lymphocytic Leukemia and Comorbidities

S1 E56 • 35 mins

Jun 22, 2025

55 - Midostaurin plus Chemotherapy for Acute Myeloid Leukemia with a FLT3 Mutation

S1 E55 • 37 mins

Jun 2, 2025

54 - Epcoritamab, a Novel, Subcutaneous CD3xCD20 Bispecific T-Cell–Engaging Antibody, in Relapsed or Refractory Large B-Cell Lymphoma: Dose Expansion in a Phase I/II Trial

S1 E54 • 40 mins

言語
ポルトガル語
ブラジル
Feed Host
ウェブサイト
フィード
更新をリクエストする
更新には数分かかる場合があります。